bimagrumab tirzepatide Update from #ADA2025 : 🧬 Bimagrumab Targets Activin Pathway in Obesity – Dual Action Molecule 👨‍⚕️ #ADA2025 #Obesity #WeightLoss 🔹 What is Bimagrumab? A monoclonal antibody that blocks activin type II A Study to Investigate Weight

How Side Effects Are Reported After a drug is approved, doctors, nurses, and pharmacists continue to watch for side effects

Does Semaglutide Have Known Risks for People with Bipolar Disorder

Hey Chat So by no means am I done with my transformation BUT Im making so much progress and wanted to share with my future group chat

Evaluation of gastric content in fasting patient during semaglutide use: an observational study

Patients interested in weight management options should speak with their GP, who can advise on currently available, evidence-based treatments through the NHS

Higher temperatures accelerate degradation exponentially